DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Cell CycleCell Cycle
  5. /ChkChk
  6. /PROTAC Chk1 degrader-1PROTAC Chk1 degrader-1
Chemical structure of CAS 2597167-34-3

PROTAC Chk1 degrader-1

CAS No.2597167-34-3
MDL No.N/A
MFC43H44N14O9
MW900.90
InChI KeyHUEILOSTKICPMD-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2597167-34-3
Product NamePROTAC Chk1 degrader-1
Heavy Atom Count66Rotatable Bond Count22
Atom Stereo Count1Bond Stereo Count0
HBA18HBD6
TPSA302.460 ŲCharge0
Exact Mass900.34157Complexity2672.99
pKa5.875XLogP1.781

Documentation

Similar Products

  • GLP-1 receptor agonist 14

    CAS No.3011682-51-9

  • Cefilavancin

    CAS No.722454-12-8

  • Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity

    CAS No.1316291-19-6

  • Brigimadlin

    CAS No.2095116-40-6

  • DBCO-|A-Glu-PEG12-Exatecan

    CAS No.3025107-83-6

  • Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-

    CAS No.162652-95-1

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact